Visentin A - Search Results

1

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.

Pagano L, Criscuolo M, Broccoli A, Piciocchi A, Varettoni M, Galli E, Anastasia A, Cantonetti M, Trentin L, Kovalchuk S, Orsucci L, Frustaci A, Spolzino A, Volpetti S, Annibali O, Storti S, Stelitano C, Marchesi F, Offidani M, Casadei B, Nizzoli ME, De Luca ML, Fianchi L, Motta M, Guarnera L, Simonetti E, Visentin A, Vassallo F, Deodato M, Sarlo C, Olivieri A, Falini B, Pulsoni A, Tiacci E, Zinzani PL. Pagano L, et al. Among authors: visentin a. Blood Cancer J. 2022 Jul 19;12(7):109. doi: 10.1038/s41408-022-00702-9. Blood Cancer J. 2022. PMID: 35853850 Free PMC article.

2

Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.

Visentin A, Compagno N, Cinetto F, Imbergamo S, Zambello R, Piazza F, Semenzato G, Trentin L, Agostini C. Visentin A, et al. Haematologica. 2015 Dec;100(12):e515-8. doi: 10.3324/haematol.2015.126763. Epub 2015 Aug 20. Haematologica. 2015. PMID: 26294735 Free PMC article. No abstract available.

3

Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia.

Visentin A, Gurrieri C, Imbergamo S, Lessi F, Di Maggio SA, Frezzato F, Adami F, Zambello R, Piazza F, Semenzato G, Trentin L. Visentin A, et al. Hematol Oncol. 2017 Dec;35(4):925-928. doi: 10.1002/hon.2343. Epub 2016 Sep 19. Hematol Oncol. 2017. PMID: 27641225 No abstract available.

4

Primary neurolymphomatosis as clinical onset of chronic lymphocytic leukemia.

Briani C, Visentin A, Cavallaro T, Cacciavillani M, Cabrini I, Ferrari S, Zambello R, Trentin L. Briani C, et al. Among authors: visentin a. Ann Hematol. 2017 Jan;96(1):159-161. doi: 10.1007/s00277-016-2852-2. Epub 2016 Oct 19. Ann Hematol. 2017. PMID: 27761605 No abstract available.

5

Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.

Briani C, Visentin A, Salvalaggio A, Imbergamo S, Piazza F, Cacciavillani M, Campagnolo M, Frezzato F, Semenzato G, Trentin L. Briani C, et al. Among authors: visentin a. Haematologica. 2017 Apr;102(4):e140-e143. doi: 10.3324/haematol.2016.153064. Epub 2016 Dec 7. Haematologica. 2017. PMID: 27927770 Free PMC article. No abstract available.

6

Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients.

Visentin A, Imbergamo S, Gurrieri C, Frezzato F, Trimarco V, Martini V, Severin F, Raggi F, Scomazzon E, Facco M, Piazza F, Semenzato G, Trentin L. Visentin A, et al. Eur J Cancer. 2017 Feb;72:103-111. doi: 10.1016/j.ejca.2016.11.020. Epub 2016 Dec 24. Eur J Cancer. 2017. PMID: 28027513

7

Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia.

Rampazzo E, Bojnik E, Trentin L, Bonaldi L, Del Bianco P, Frezzato F, Visentin A, Facco M, Semenzato G, De Rossi A. Rampazzo E, et al. Among authors: visentin a. Haematologica. 2017 Jul;102(7):e253-e256. doi: 10.3324/haematol.2016.157669. Epub 2017 Apr 6. Haematologica. 2017. PMID: 28385779 Free PMC article. No abstract available.

8

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death.

Mandato E, Nunes SC, Zaffino F, Casellato A, Macaccaro P, Tubi LQ, Visentin A, Trentin L, Semenzato G, Piazza F. Mandato E, et al. Among authors: visentin a. Curr Cancer Drug Targets. 2018;18(6):608-616. doi: 10.2174/1568009617666170427110450. Curr Cancer Drug Targets. 2018. PMID: 28460620

9

Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases.

Visentin A, Imbergamo S, Frezzato F, Pizzi M, Bertorelle R, Scomazzon E, Berno T, Riva M, Piva E, Facco M, Piazza F, Semenzato G, Trentin L. Visentin A, et al. Oncotarget. 2017 Sep 28;8(66):110727-110731. doi: 10.18632/oncotarget.21304. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299182 Free PMC article.

10

The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma.

Canovas Nunes S, Manzoni M, Pizzi M, Mandato E, Carrino M, Quotti Tubi L, Zambello R, Adami F, Visentin A, Barilà G, Trentin L, Manni S, Neri A, Semenzato G, Piazza F. Canovas Nunes S, et al. Among authors: visentin a. Blood Cancer J. 2018 Feb 13;8(2):20. doi: 10.1038/s41408-018-0053-z. Blood Cancer J. 2018. PMID: 29440639 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters